1 Clinical Medical College and Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan University of Science and Technology, Luoyang 471023, People’s Republic of China
2 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210008, People’s Republic of China
3 Institute of Organoids on Chips Translational Research, Henan Academy of Sciences, Zhengzhou 450003, People’s Republic of China
Funds:
This work was financially supported by the National Key Research and Development Program of China (2022YFE132800), Innovation Scientists and Technicians Troop Construction Projects of Henan Province (CXTD2017071), Key R&D Project of Henan Province (221111310600), and Special Foundation for Basic Research Program of Higher Education Institutions of Henan Province (22ZX005).
Esophageal cancer (EC) is characterized by high morbidity and mortality, and chemotherapy has become an indispensable means for comprehensive treatment. However, due to the limitation of the effective in vitro disease model, the development of chemotherapeutic agents still faces great challenges. In this paper, we present a novel tumor spheroid on a chip platform based on inverse opal hydrogel scaffolds to screen chemotherapeutic agents for EC treatment. With the microfluidic emulsion approach, the inverse opal hydrogel scaffolds were generated with tunable and organized pores, which could provide spatial confinement for cell growth. Thus, the suspended KYSE-70 cells could successfully form uniform cell spheroids on the inverse opal hydrogel scaffolds. It was demonstrated that the tumor cell spheroids could recapitulate 3D growth patterns in vivo and exhibited higher sensitivity to the chemotherapy agents compared with monolayer cells. Besides, by employing the scaffolds into a microfluidics to construct esophageal tumor on a chip, the device could realize high-throughput tumor cell spheroids generation and drug screening, indicating its promising role in chemotherapy drug development.